Dr. Bosco Paes
Professor Emeritus, Pediatrics
Ph: 905-521-2100 x73672
Infectious Diseases (Respiratory Syncytial Virus)
Primary Theme: Neonatalogy (infections)
Secondary Theme: Hematology
Respiratory Syncytial Virus, Cost-effectiveness, Thrombocytopenia, Late-Preterm Infants
Research Program Overview
Review of the epidemiology of respiratory syncytial virus (RSV) infections in Canada particularly in high risk populations and determining risk factors that may target the use of prophylaxis more cost-effectively in specific cohorts of infants.
Data is being collected in a registry with the primary objective of providing insight into the current management, annual utilization and compliance of infants at high-risk of RSV infections with palivizumab prophylaxis in tertiary care centres and community settings. The cost-effectiveness of prophylaxis in quality adjusted life-years is also being assessed.
My other foci are on neonatal alloimmune thrombocytopenia and thrombosis, outcomes of late-preterm infants, pre-medication for neonatal intubation, jaundice and quality improvement.
- The Canadian Registry of Synagis (CARESS Protocol)
- Cost-effective study of palivizumab prophylaxis in Northern Canadian Communities
- Outcomes of Late Preterm Infants
- Remifentanyl as a pre-medication for elective intubation in neonates
Publications & Achievements
- Loovere L, Boyle EM, Blatz S, Paes B et al. Can Assoc Radiol J 2008;59:197-202
- Rodriguez-Capote K, Kim K, Paes B et al. Clin Biochem 2009;42:176-179
- Lanctot KL, Masoud ST, Paes BA et al. Curr Med Res Opin 2008;24:3223-3237
- Sampalis JS, Langley J, Carbonell-Estrany X, Paes B et al. Med Decis Making 2008;28:471-480
- Bassler D, Greinacher A, Paes B et al. Transfusion.2008; 48:92-8
Phone: 905-521-2100 x76026
Title: Research Assistant